Background: Occupational exposure to blood and body fluids has become a serious public health problem for healthcare workers and is a major risk for the transmission of bloodborne infections such as human immune-deficiency, hepatitis B, and hepatitis C viruses. It has been identified as one of the most serious issues affecting the health and well-being of health workers in most health systems especially in developing countries. The present systematic review and meta-analysis was conducted to estimate the pooled prevalence of blood and other body fluids exposures among healthcare workers in Cameroon. Methods: Online platform including PubMed, Google Scholar, Cochrane Library, and Science Direct were systematically searched to collect relevant research reports. Unpublished studies in a national library were also consulted. The I2 tests were used to assess the heterogeneity of the included studies. A fixed and random-effects meta-analysis model was used to estimate the lifetime and 12-month prevalence of occupational exposure to blood and other body fluids among healthcare workers in Cameroon. Results: Of the 539 records identified through the database search, 15 study reports were included in the final analysis. The random-effects model showed that the estimated overall pooled prevalence of 12-month and lifetime exposure to blood and other body fluids among healthcare workers in Cameroon was 55.44% (95% Confidence Interval (CI): 41.20-69.68); (I2=97.5%; p<0.001) and 57.27% (95% CI: 42.43-72.10); (I2=97.7%; p<0.001) respectively. The highest 12-month pooled prevalence was observed in intermediate level health facilities (84.73%; 95% CI: 85.55-88.50), in Regions other than the Centre (70.87%; 95% CI: 37.26-95.13) and for studies conducted from 2017 to 2023 (65.63%; 95% CI: 45.73-83.06). The lifetime prevalence of blood and other body fluids exposures was the highest for Regions namely the North-west and South-west Regions (77.96%; 95% CI: 57.39-93.19). Conclusion: Healthcare workers in Cameroon face a significant risk of occupational exposure to blood and body fluids (BBFs), with a high prevalence of exposure over their lifetime and in the past 12 months. This highlights the urgent need to enhance and implement effective occupational safety and health policies to protect healthcare workers in Cameroon.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Source data were openly available before the initiation of the study. Links to included research article are available in the reference of the paper. https://doi.org/10.1186/s12913-024-10855-x https://www.opastpublishers.com/peer-review/accidental-exposure-to-body-fluids-among-healthcare-workers-in-a-referral-hospital-in-the-securitychallenged-region-of-s-7302.html http://dx.doi.org/10.34297/AJBSR.2023.19.002628 https://www.primescholars.com/articles/infection-risk-perception-reporting-and-postexposure-management-of-occupational-injuries-among-healthcare-workers-in-district-hosp-123143.html https://bmcmededuc.biomedcentral.com/articles/10.1186/1472-6920-13-148 https://journalmrji.com/index.php/MRJI/article/view/56 https://journalmrji.com/index.php/MRJI/article/view/56 https://doi.org/10.21522/TIJPH.2013.05.04.Art029 https://doi.org/10.11604/pamj.2018.29.158.14073 http://www.biomedcentral.com/1756-0500/9/94 https://www.mdpi.com/1660-4601/7/5/2085

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript